GSA Capital Partners LLP Boosts Stake in Semler Scientific, Inc. (NASDAQ:SMLR)

GSA Capital Partners LLP lifted its holdings in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 73.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,336 shares of the company’s stock after buying an additional 4,393 shares during the period. GSA Capital Partners LLP owned approximately 0.15% of Semler Scientific worth $243,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the business. Shariaportfolio Inc. bought a new stake in shares of Semler Scientific in the third quarter worth approximately $3,618,000. AQR Capital Management LLC grew its position in Semler Scientific by 150.1% in the 2nd quarter. AQR Capital Management LLC now owns 140,498 shares of the company’s stock worth $4,833,000 after purchasing an additional 84,314 shares during the period. Dimensional Fund Advisors LP raised its stake in Semler Scientific by 18.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company’s stock valued at $4,341,000 after buying an additional 19,552 shares during the last quarter. Citizens Financial Group Inc. RI bought a new position in shares of Semler Scientific during the 2nd quarter valued at $585,000. Finally, Jacobs Levy Equity Management Inc. boosted its stake in shares of Semler Scientific by 20.6% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 98,252 shares of the company’s stock worth $2,870,000 after buying an additional 16,777 shares during the last quarter. Hedge funds and other institutional investors own 49.37% of the company’s stock.

Insider Activity

In other Semler Scientific news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the business’s stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $28.35, for a total value of $283,500.00. Following the sale, the chief executive officer now owns 60,220 shares in the company, valued at $1,707,237. The trade was a 14.24 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 30.20% of the company’s stock.

Semler Scientific Stock Performance

Semler Scientific stock opened at $63.65 on Friday. Semler Scientific, Inc. has a one year low of $20.88 and a one year high of $76.98. The stock has a fifty day moving average of $32.45 and a 200 day moving average of $30.76. The stock has a market cap of $462.74 million, a PE ratio of 31.05 and a beta of 0.92.

Semler Scientific (NASDAQ:SMLR) last released its quarterly earnings results on Monday, November 4th. The company reported $0.72 EPS for the quarter, beating the consensus estimate of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The firm had revenue of $13.51 million during the quarter.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.